VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVNTAvient Corporation
$37.91$3.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAVNTFinancials

Avient Corporation (AVNT) Financials

27Y historyFree accessUpdated daily

Revenue growth remains modest at 2.5% year-over-year as of 2026Q1, while operating margins continue to fluctuate significantly, ranging from 0.1% to 11.6% over the last ten quarters.

AVNT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue3.28B3.26B3.24B3.14B3.4B3.32B3.24B2.86B3.53B3.23B3.34B3.38B3.84B3.77B2.99B2.86B2.62B2.06B2.74B2.64B2.62B2.45B2.16B1.96B2.5B2.65B1.89B1.26B
Revenue Growth %1.33%0.61%3.11%-7.48%2.46%2.26%13.25%-18.98%9.4%-3.29%-1.12%-11.94%1.7%26.02%4.51%9.21%27.23%-24.76%3.63%0.77%7.01%13.38%10.03%-21.36%-5.89%40.62%49.68%-
Cost of Goods Sold2.24B2.2B2.18B2.24B2.51B2.37B2.46B2.21B2.79B2.51B2.63B2.7B3.13B3.11B2.43B2.4B2.19B1.74B2.44B2.34B2.28B2.15B1.84B1.66B2.1B2.22B1.6B1.03B
COGS % of Revenue-67.54%67.39%71.28%74.01%71.53%75.81%77.04%78.92%77.74%78.86%79.82%81.54%82.44%81.14%83.84%83.64%84.36%89.17%88.44%87.05%87.88%85.01%84.74%83.99%83.74%84.69%81.58%
Gross Profit1.04B1.06B1.06B902.7M882.7M943.8M784.3M657.2M744.9M719M706.2M681.5M707.9M662.2M564.3M462.7M428.9M322.2M296.6M305.4M339.7M297.1M324M299.8M400M431.6M289M232.3M
Gross Margin %31.74%32.46%32.61%28.72%25.99%28.47%24.19%22.96%21.08%22.26%21.14%20.18%18.46%17.56%18.86%16.16%16.36%15.64%10.83%11.56%12.95%12.12%14.99%15.26%16.01%16.26%15.31%18.42%
Gross Profit Growth %-0.14%17.06%2.27%-6.47%20.34%19.34%-11.77%3.6%1.81%3.62%-3.73%6.9%17.35%21.96%7.88%33.12%8.63%-2.88%-10.1%14.34%-8.3%8.07%-25.05%-7.32%49.34%24.41%-
Operating Expenses734.5M854.7M727.4M681.2M639.4M664.1M595M500.4M471.2M441.5M424.3M430.6M552.8M457.6M420.6M229.7M254.6M237.1M558.7M271.5M149.5M156.8M204.4M303.8M361.1M442.8M214.7M132.6M
OpEx % of Revenue-26.22%22.45%21.67%18.82%20.03%18.35%17.48%13.34%13.67%12.7%12.75%14.41%12.13%14.05%8.02%9.71%11.51%20.4%10.27%5.7%6.4%9.46%15.46%14.45%16.68%11.37%10.51%
Selling, General & Admin701.1M695.4M727.4M590.9M639.4M664.1M595M500.4M471.2M441.5M424.3M430.6M552.8M457.6M420.6M381.7M296.6M272.3M287.1M241.8M201.3M178.2M201.2M243.8M302.6M304.2M191.5M97.4M
SG&A % of Revenue-21.33%22.45%18.8%18.82%20.03%18.35%17.48%13.34%13.67%12.7%12.75%14.41%12.13%14.05%13.33%11.31%13.21%10.48%9.15%7.68%7.27%9.31%12.41%12.11%11.46%10.14%7.72%
Research & Development0098.7M90.3M84.9M00049.6M52.1M50.4M53M53.4M52.6M41.3M0000000000000
R&D % of Revenue--3.05%2.87%2.5%---1.4%1.61%1.51%1.57%1.39%1.39%1.38%-------------
Other Operating Expenses1000K159.3M-98.7M0-84.9M000-12.6M-4.1M600K-2.7M-4.5M-1.2M-3.3M-152M-42M-35.2M271.6M29.7M-51.8M-21.4M3.2M60M58.5M138.6M23.2M35.2M
Operating Income306.9M203.5M329.3M221.5M243.3M279.7M189.3M156.8M273.7M277.5M281.9M250.9M155.1M231.5M167.1M233M174.3M80.1M-129.3M33.9M190.2M140.3M119.6M-4M38.9M-17.1M64.8M99.7M
Operating Margin %9.35%6.24%10.16%7.05%7.16%8.44%5.84%5.48%7.75%8.59%8.44%7.43%4.04%6.14%5.58%8.14%6.65%3.89%-4.72%1.28%7.25%5.73%5.53%-0.2%1.56%-0.64%3.43%7.91%
Operating Income Growth %--38.2%48.67%-8.96%-13.01%47.75%20.73%-42.71%-1.37%-1.56%12.36%61.77%-33%38.54%-28.28%33.68%117.6%161.95%-481.42%-82.18%35.57%17.31%3090%-110.28%327.49%-126.39%-35%-
EBITDA495.4M389.4M509M410.3M406.4M425.6M304.3M244.3M369.4M375.1M365.9M366.6M279M341.3M236.9M290.5M229.5M144.9M-61.3M91.3M247.3M191M170.5M47.4M111.4M74.2M122.2M144.1M
EBITDA Margin %15.1%11.94%15.71%13.06%11.96%12.84%9.39%8.53%10.45%11.61%10.96%10.85%7.27%9.05%7.92%10.14%8.75%7.03%-2.24%3.45%9.43%7.79%7.89%2.41%4.46%2.8%6.47%11.43%
EBITDA Growth %19.89%-23.5%24.06%0.96%-4.51%39.86%24.56%-33.87%-1.52%2.51%-0.19%31.4%-18.25%44.07%-18.45%26.58%58.39%336.38%-167.14%-63.08%29.48%12.02%259.7%-57.45%50.13%-39.28%-15.2%-
D&A (Non-Cash Add-back)188.5M185.9M179.7M188.8M163.1M145.9M115M87.5M95.7M97.6M84M115.7M123.9M109.8M69.8M57.5M55.2M64.8M68M57.4M57.1M50.7M50.9M51.4M72.5M91.3M57.4M44.4M
EBIT343.3M362.8M330.4M202.6M183.6M278.7M213.6M168.9M169.4M273.8M287.1M238M150.6M214.5M134.1M202.6M142.8M70.5M-133.9M33.9M190.2M140.3M128.4M-14.9M5M-45.3M73.4M99.7M
Net Interest Income-67.8M-98.6M-105.6M-115.3M-148.3M-87.6M-81.8M-59.5M-62.8M-60.8M-59.7M-64M-62.2M-63.5M-50.8M-33.7M-31.5M-34.3M-37.2M-81.2M-79.5M-97M-114.8M-290.3M0000
Interest Income000034M17.5M0000000000003.4M4.5M3.4M1.9M1.5M900K0000
Interest Expense67.8M98.6M105.6M115.3M182.3M105.1M81.8M59.5M62.8M60.8M59.8M64.1M62.2M63.5M50.8M33.7M31.5M34.3M40.6M85.7M82.9M98.9M116.3M291.2M118.4M117.5M64.1M0
Other Income/Expense-96.3M-91.8M-104.5M-134.2M-179.5M-76.2M-50.3M-47.4M-76.8M-65.2M-55.3M-83.2M-66.7M-80.5M-54.1M-34.3M-63.3M-25.6M-41.8M-66.3M-70.3M-71.5M-78.3M-68.1M-16.8M-80.7M-39.3M74.3M
Pretax Income210.6M111.7M224.8M87.3M63.8M203.5M139M109.4M197.2M212.3M222.3M167.7M88.4M151M113M198.7M111M36.2M-171.1M-32.4M119.9M68.8M32.2M-83M-11.8M-71.7M26.1M174M
Pretax Margin %6.42%3.43%6.94%2.78%1.88%6.14%4.29%3.82%5.58%6.57%6.66%4.97%2.3%4%3.78%6.94%4.23%1.76%-6.25%-1.23%4.57%2.81%1.49%-4.23%-0.47%-2.7%1.38%13.8%
Income Tax51.3M28.1M54.1M11M-19.3M51.9M5.2M33.7M36.4M38.7M57.3M23M11.2M58.1M41.2M26.1M-51.6M-13.3M101.8M-43.8M-6M6.6M13.6M12.3M-5.2M-25.6M10.2M67.8M
Effective Tax Rate %24.36%25.16%24.07%12.6%-30.25%25.5%3.74%30.8%18.46%18.23%25.78%13.71%12.67%38.48%36.46%13.14%-46.49%-36.74%-59.5%135.19%-5%9.59%42.24%-14.82%44.07%35.7%39.08%38.97%
Net Income157.8M81.9M169.5M75.7M153M230.8M131.6M588.6M159.8M-57.7M165.2M144.6M79.2M243.8M71.9M172.6M162.6M49.5M-272.9M11.4M123.2M46.9M23.5M-251.1M-58.9M-46.1M15.9M104.7M
Net Margin %4.81%2.51%5.23%2.41%4.5%6.96%4.06%20.56%4.52%-1.79%4.95%4.28%2.06%6.46%2.4%6.03%6.2%2.4%-9.96%0.43%4.7%1.91%1.09%-12.78%-2.36%-1.74%0.84%8.3%
Net Income Growth %57.96%-51.68%123.91%-50.52%-33.71%75.38%-77.64%268.34%376.95%-134.93%14.25%82.58%-67.51%239.08%-58.34%6.15%228.48%118.14%-2493.86%-90.75%162.69%99.57%109.36%-326.32%-27.77%-389.94%-84.81%-
Net Income (Continuing)159.3M83.6M170.7M76.3M83.1M151.6M133.8M75.7M87.4M173.6M166.2M148.5M77.2M92.9M71.8M172.6M162.6M49.5M-272.9M11.4M125.9M62.2M27.6M-106.4M-25.3M-59.2M15.2M106.2M
Discontinued Operations000-100K70.2M79M-400K513.1M72.1M0001.2M000000000000000
Minority Interest12.2M12.1M15.8M18.8M18.3M15.8M14.6M800K600K900K800K1M900K1.7M2.3M0000300K5.5M5.4M6.8M8.5M9M15.7M14M5.7M
EPS (Diluted)1.720.891.840.821.662.511.450.971.99-0.701.951.630.852.530.801.831.690.53-2.940.121.330.510.26-2.76-0.64-0.510.262.15
EPS Growth %60.75%-51.63%124.39%-50.6%-33.86%73.1%49.48%-51.26%384.29%-135.9%19.63%91.76%-66.4%216.25%-56.28%8.28%218.87%118.03%-2550%-90.98%160.78%96.15%109.42%-331.25%-25.49%-296.15%-87.91%-
EPS (Basic)-0.901.860.837.712.531.460.982.01-0.711.971.650.862.550.811.871.750.54-2.940.121.330.510.26-3.07-0.65-0.510.262.25
Diluted Shares Outstanding91.9M91.8M92M91.8M92.2M92.1M90.6M77.7M80.4M82.1M84.6M88.7M93.5M96.5M89.8M94.3M96M93.4M92.7M93.1M92.8M92M91.8M91M92.1M90.4M62M48.6M
Basic Shares Outstanding91.7M91.5M91.3M91.1M91.2M91.4M90.1M77.2M79.7M81.5M83.9M87.8M92.3M95.5M89.1M92.2M93.1M92.4M92.7M92.8M92.4M91.9M91.6M81.79M90.62M90.39M61.4M46.6M
Dividend Payout Ratio-120.63%55.46%119.15%56.73%33.67%54.18%10.24%35.11%-24.33%24.69%37.75%8.82%23.5%6.43%14.88%66.46%--------93.71%11.27%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetStrained
Cash FlowImproving
Top Statement Risk

High Debt Leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Remains Modestly Variable

According to recent quarterly filings, Avient's revenue growth has exhibited a mixed trajectory, with the most recent period showing a 2.5% year-over-year increase to $847.4 million, reflecting the ongoing challenges of navigating a post-divestiture portfolio while managing cyclical demand in its core specialty chemical markets.

The revenue trend suggests that the company is struggling to find a consistent growth cadence following the divestiture of its distribution business. While the recent 2.5% growth indicates some stabilization, investors should monitor whether the company can achieve sustained organic expansion without the volume-heavy contribution of its former segments.

Structural Gross Margin Resilience Observed

As reported in financial statements, Avient has maintained a gross margin profile hovering around 32%, a figure that appears to validate the company's strategic pivot toward higher-value, specialty-formulated products that command greater pricing power than the commodity-heavy resin business it previously operated.

The stability of the 32% gross margin suggests that the company's 'spec-in' strategy is effectively insulating it from the worst of raw material price volatility. However, the inability to consistently push margins significantly higher warrants further investigation into whether competitive pressures are limiting the pass-through of costs.

Operating Leverage Constrained by Costs

Based on Avient's reported figures, operating income has shown significant volatility, with margins fluctuating between 0.1% and 11.6% over the last ten quarters, indicating that the company has yet to achieve the consistent operating leverage expected from its high-margin specialty chemical business model.

The wide variance in operating margins suggests that SG&A expenses remain somewhat rigid relative to revenue fluctuations. This lack of consistent operating leverage may imply that the company is still absorbing integration costs or restructuring expenses that prevent the full realization of scale benefits.

Net Income Impacted by Volatility

Financial disclosures reveal that net income has been highly inconsistent, ranging from a $20.2 million loss in 2025Q1 to a $55.7 million profit in 2026Q1, largely due to the impact of non-operating items and the ongoing integration of large-scale acquisitions like Dyneema.

The erratic nature of net income appears to be a byproduct of purchase price accounting and restructuring charges rather than purely operational failure. Investors should monitor whether these 'special items' continue to suppress earnings quality or if the company is approaching a period of cleaner, more predictable profitability.

Debt Burden Risks Future Flexibility

Analysis of the company's recent financial performance suggests that the aggressive acquisition strategy has left the balance sheet in a strained position, with significant debt service requirements potentially limiting the capital available for R&D and organic growth initiatives in the near term.

Short-sellers might focus on the high debt-to-EBITDA levels, which could become a liability if interest rates remain elevated or if end-market demand for high-performance materials softens. The company's ability to deleverage will be the primary test of management's capital allocation strategy over the coming fiscal years.

AVNT — Frequently Asked Questions

Quick answers to the most common questions about buying AVNT stock.

What was Avient Corporation's (AVNT) revenue in 2025?

For fiscal year 2025, Avient Corporation (AVNT) reported total revenue of $3.26B. This represents a 158.5% increase compared to $1.26B in 1999.

Is Avient Corporation (AVNT) profitable?

Avient Corporation (AVNT) is profitable, generating $81.9M in net income for the fiscal year ending 2025 with a net profit margin of 2.5%.

What is Avient Corporation's operating profit margin?

Avient Corporation (AVNT) reported an operating income of $203.5M, resulting in an operating profit margin of 6.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Avient Corporation's gross profit and gross margin?

Avient Corporation (AVNT) generated $1.06B in gross profit for the year, representing a gross profit margin of 32.5%. This demonstrates the company's core pricing power and production efficiency.